The Sir Ganga Ram Hospital is a 675-bed multi-speciality private hospital in Rajendra Nagar, Delhi. It provides comprehensive medical services to patients from all over Southeast Asia. The hospital's Minimal Access Surgery department was the first such department in South Asia.

There are 675 beds in Sir Ganga Ram Hospital.

During the past decade, Sir Ganga Ram Hospital conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 31 clinical trials were completed, i.e. on average, 36% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 24 clinical trials were completed. i.e. 96% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sir Ganga Ram Hospital" #1 sponsor was "Eli Lilly and Company" with 22 trials, followed by "Sir Ganga Ram Hospital" with 10 trials sponsored, "Boehringer Ingelheim" with 6 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored and "Hoffmann-La Roche" with 6 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sir Ganga Ram Hospital" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Sir Ganga Ram Hospital" with 2 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Sir Ganga Ram Hospital" are "Atopic Dermatitis" (5 trials), "Pulmonary Arterial Hypertension" (4 trials), "Crohn's Disease" (3 trials), "Dyslipidemia" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Sir Ganga Ram Hospital" in a lesser frequency.

Most popular intervention types in "Sir Ganga Ram Hospital" are "Drug" (87 trials), "Other" (12 trials), "Biological" (7 trials), "Device" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "Baricitinib" (8 trials), "Propofol" (4 trials), "Desflurane" (3 trials) and "Empagliflozin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sir Ganga Ram Hospital" are 105 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Sir Ganga Ram Hospital". undefined are not yet recruiting, 29 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 57 completed trials in Sir Ganga Ram Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Sir Ganga Ram Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 9 trials that are defined as “Not Applicable".

Sir Ganga Ram Hospital has several departments that took part in Clinical trials: "Department of Gastroenterology & Hepatology, Sir Ganga Ram Hospital" - 5 trials